#biotechnology - Techseriesinsight

November 7, 2025
Business Wire
Biotechnology, News

Gilead Provides Update on Phase 3 ASCENT-07 Study

Today announced the Phase 3 ASCENT-07 study investigating Trodelvy® versus chemotherapy as a first-line treatment post-endocrine therapy in HR+/HER2-negative metastatic breast cancer patients did not meet the primary endpoint of...

November 5, 2025
PRNewswire
Blockchain Technology, News

Hyperscale Data Announces Completion of $125 Million At-The-Market Program, Strengthening Its Position as a Bitcoin-Anchored AI Infrastructure Platform Provider

An artificial intelligence (“AI“) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company“), today announced the successful completion of its previously disclosed at-the-market (“ATM“) equity program, strengthening the Company’s balance...

November 5, 2025
Business Wire
Biotechnology, News

Charles River Laboratories Provides Update on Strategic Review

Charles River Laboratories International, Inc. (NYSE: CRL) today announced an update on its Board of Directors’ comprehensive strategic review of the Company’s business and growth prospects. The Board strongly...

October 20, 2025
Business Wire
Biotechnology, News

Rhythio Medical Receives FDA Breakthrough Device Designation for Injectable Electrode Technology Enabling Painless, Imperceptible Defibrillation

Rhythio Medical, a medical device company pioneering injectable bioelectronic therapies, today announced that its Injectable Electrode System has received Breakthrough Device Designation from the U.S. Food and Drug Administration...

October 16, 2025
PRNewswire
Biotechnology, News

Philadelphia Biotech, LIV Process Unveils Breakthrough “Microbial Visualization” Technology

As infectious disease leaders gather in Atlanta for IDWeek 2025 (October 19–22), Philadelphia-based biotech, LIV Process is shining a light on one of healthcare’s most persistent challenges: healthcare-associated infections (HAIs). LIV Process,...

September 15, 2025
Business Wire
Biotechnology, Healthcare, News

Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, announced today it has enrolled the first patient in a multi-country Phase 2 trial...

lab image, Raytone-Biotech-Announces-First-Patient

August 4, 2025
PRNewswire
Biotechnology, Healthcare, News

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing in its clinical trial of RTP-008 during Q2 2025....

June 26, 2025
PRNewswire
Biotechnology, Healthcare, News

Cellarity Starts Phase 1 Trial of CLY-124 for Sickle Cell

Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that the first subject has been dosed in a Phase 1 clinical trial...

Cyrex Launches BiomeBurden™ for Immune Sensitivity Testing

June 20, 2025
PRNewswire
Biotechnology, News

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will host an investor webcast presentation on June...

June 12, 2025
PRNewswire
Biotechnology

Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases

Nona Biosciences, a global biotechnology company providing integrated solutions from “Idea to IND” (I to ITM), today announced a license agreement with Visterra, Inc. to advance Visterra’s next-generation biotherapeutic pipeline for immune-mediated...